| Saadia Khan Whatley, Dpm L.l.c. | |
|
2 Office Park Ct Ste 103, Columbia, SC 29223-5948 | |
| (256) 497-0032 | |
| Not Available |
| Full Name | Saadia Khan Whatley, Dpm L.l.c. |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 2 Office Park Ct Ste 103, Columbia, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942634001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 629 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Saadia Khan Whatley, Dpm L.l.c. 910 Spindle St Apt 402, Charlotte, NC 28206-3336 Ph: (256) 497-0032 | Saadia Khan Whatley, Dpm L.l.c. 2 Office Park Ct Ste 103, Columbia, SC 29223-5948 Ph: (256) 497-0032 |
News Archive
62% of school-age children and 85% of pregnant women in Israel have low iodine intakes, according to the country's first national iodine survey. Government funding and legislation, and a government-regulated program of salt or food iodization, are essential to reducing the deficiency, which poses a high risk of impaired neurological development.
An international research team, led by Dartmouth's Peter A. Kaufman, MD, published findings today in the Journal of Clinical Oncology demonstrating that, while not superior to capecitabine, eribulin is an active and well-tolerated therapy in women with metastatic breast cancer (MBC) receiving this therapy as a first, second, or third line chemotherapy regimen.
AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.
deCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE's DNA-based prostate cancer risk assessment test to its clients nationwide.
A chemically-modified version of a mitochondrial toxin long used to control species of invasive fish in lakes has been found to selectively inhibit two "survival proteins" in cancer cells.
› Verified 3 days ago
Dr. Maureen Quinlan, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1730 Saint Julian Pl, Columbia, SC 29204 Phone: 803-256-6776 Fax: 803-256-6778 | |
Elgin Podiatry Institute, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 3 Richland Medical Park Dr, Suite 110, Columbia, SC 29203 Phone: 803-807-9388 Fax: 803-807-9391 | |
Dr. Carly Chapman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1516 Calhoun St, Columbia, SC 29201 Phone: 803-254-6114 Fax: 803-254-7674 | |
James A Suber, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1516 Calhoun St, Columbia, SC 29201 Phone: 803-254-6114 Fax: 803-254-7674 | |
Carolina Family Podiatry,llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 131 Wildewood Park Dr, Columbia, SC 29223 Phone: 803-462-7040 Fax: 803-462-7047 | |
Thomas A F Pinner, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2200 Harden St, Columbia, SC 29203 Phone: 803-898-8405 Fax: 808-898-8526 | |
Prisma Health Medical Group-midlands Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3 Richland Medical Park Dr Ste 350, Columbia, SC 29203 Phone: 803-434-6838 Fax: 803-434-6878 |